Registry to analyze melanoma risk factors in Spain

Registro de Melanoma de la AEDV

This study is collecting information from people with melanoma in Spain to see how different social and healthcare factors might affect their outcomes.

Quick facts

• Study type: Observational
• Enrollment: 7000 (estimated)
• Sex: All
• Sponsor: Fundación Academia Española de Dermatología (Academic / other)
• Locations: 21 sites (Badalona, Barcelona and 20 other locations)
• Trial ID: NCT05673681 on ClinicalTrials.gov

What this trial studies

This observational registry aims to gather data on patients diagnosed with invasive primary cutaneous melanoma in Spain to identify socioeconomical and healthcare-related risk factors that may influence prognosis. The study will collect information on individual characteristics such as gender, residence area, and socioeconomic status, as well as healthcare factors like waiting times and the type of diagnostic center. Participants will be monitored without any changes to their treatment protocols, allowing for a comprehensive analysis of the factors affecting melanoma outcomes.

Who should consider this trial

Good fit: Ideal candidates for this registry are patients with a diagnosis of invasive primary cutaneous melanoma.

Not a fit: Patients with in-situ melanomas, non-cutaneous melanomas, or metastatic melanoma with an unknown primary site may not benefit from this registry.

Why it matters

Potential benefit: If successful, this registry could provide valuable insights that lead to improved prognosis and management strategies for melanoma patients.

How similar studies have performed: Other observational studies have successfully identified risk factors for melanoma prognosis, suggesting that this approach could yield valuable findings as well.

Eligibility criteria

Inclusion Criteria:

* All consecutive patients with a diagnosis of invasive primary cutaneous melanoma in participating centres.

Exclusion Criteria:

* In-situ melanomas
* non-cutaneous melanomas,
* metastatic melanoma with unknown primary site.

Where this trial is running

Badalona, Barcelona and 20 other locations

• Hospital Universitari Germans Trias i Pujol — Badalona, Barcelona, Spain (Recruiting)
• Complexo Hospitalario Universitario de A Coruña — A Coruña, Spain (Not_yet_recruiting)
• Hospital Clinic — Barcelona, Spain (Recruiting)
• Hospital San Juan de Dios — Córdoba, Spain (Recruiting)
• Hospital Universitario de Gran Canaria Dr Negrín — Las Palmas, Spain (Recruiting)
• Complejo Asistencial Universitario de León — León, Spain (Recruiting)
• Clínica Dermatológica Internacional — Madrid, Spain (Not_yet_recruiting)
• Clínica Universitaria de Navarra ( sede de Madrid) — Madrid, Spain (Recruiting)
• Hospital Clínico San Carlos — Madrid, Spain (Recruiting)
• Hospital La Paz — Madrid, Spain (Recruiting)
• Hospital Puerta de Hierro Majadahonda — Madrid, Spain (Not_yet_recruiting)
• Ruber Internacional — Madrid, Spain (Not_yet_recruiting)
• Hospital Central de Asturias — Oviedo, Spain (Recruiting)
• Hospital Son LLàtzer — Palma de Mallorca, Spain (Recruiting)
• Complexo Hospitalario Universitario de Pontevedra — Pontevedra, Spain (Not_yet_recruiting)
• H.U. Nuestra Señora de la Candelaria — Santa Cruz de Tenerife, Spain (Recruiting)
• Hospital Universitario Virgen Macarena de Sevilla — Seville, Spain (Recruiting)
• Quirón Salud Sevilla — Seville, Spain (Not_yet_recruiting)
• Hospital La Fé — Valencia, Spain (Not_yet_recruiting)
• Instituto Valenciano de Oncología — Valencia, Spain (Recruiting)
• Hospital Miguel Servet — Zaragoza, Spain (Not_yet_recruiting)

Study contacts

• Study coordinator: Mercè Grau, MD

Conditions Melanoma